jethro
Distinguished member
- Joined
- Nov 2, 2017
- Messages
- 457
- Reason
- PALS
- Diagnosis
- 09/2017
- Country
- HR
- State
- Croatia
- City
- ZAGREB
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients
Bromocriptine mesylate (BRC), a dopamine D2 receptor agonist has been shown to confer neuroprotection, sustained motor function and slowed disease progression in mouse models of amyotrophic lateral sclerosis (ALS) Here we report a first in human trial ...
www.ncbi.nlm.nih.gov